Home002294 • SHE
add
Shenzhen Salubris Pharmaceuticals Co Ltd
Nakaraang pagsara
¥55.97
Sakop ng araw
¥54.50 - ¥56.30
Sakop ng taon
¥36.81 - ¥70.99
Market cap
62.40B CNY
Average na Volume
12.34M
P/E ratio
91.50
Dividend yield
0.90%
Primary exchange
SHE
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (CNY) | Mar 2026info | Y/Y na pagbabago |
|---|---|---|
Kita | 1.23B | 15.65% |
Gastos sa pagpapatakbo | 694.36M | 18.96% |
Net na kita | 225.27M | 12.45% |
Net profit margin | 18.34 | -2.76% |
Kita sa bawat share | — | — |
EBITDA | 343.52M | 11.90% |
Aktuwal na % ng binabayarang buwis | 11.60% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (CNY) | Mar 2026info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 1.83B | -32.50% |
Kabuuang asset | 11.41B | 6.95% |
Kabuuang sagutin | 2.14B | 25.31% |
Kabuuang equity | 9.27B | — |
Natitirang share | 1.11B | — |
Presyo para makapag-book | 6.82 | — |
Return on assets | 5.43% | — |
Return on capital | 6.53% | — |
Cash Flow
Net change in cash
| (CNY) | Mar 2026info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 225.27M | 12.45% |
Cash mula sa mga operasyon | 185.28M | 9.38% |
Cash mula sa pag-invest | 22.12M | -82.65% |
Cash mula sa financing | -66.20M | -498.53% |
Net change in cash | 133.86M | -57.01% |
Malayang cash flow | -1.09B | -28.97% |
Tungkol
Shenzhen Salubris Pharmaceuticals is a Chinese pharmaceutical company.
Founded in November 1998 and based in Shenzhen, it has a market cap of US$4.4 billion, 3,121 employees and annual sales of $553 million as of 2019.
Shenzhen Salubris is headed by the billionaire Ye Chenghai. Wikipedia
Itinatag
Nob 3, 1998
Website
Mga Empleyado
4,087
